Related Experiment Video
Updated: Jun 26, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
A proposed clinical staging system for obesity
1Division of Endocrinology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. amsham@ualberta.ca
International Journal of Obesity (2005)
|February 4, 2009
Summary
Current obesity classifications lack individual clinical utility. This study proposes a new staging system to assess morbidity and functional limitations, aiding clinical decision-making for better obesity management.
Area of Science:
- Endocrinology
- Clinical Medicine
- Public Health
Background:
- Current obesity classifications rely on anthropometric measures like BMI, which are insufficient for individual clinical assessment.
- These measures do not account for comorbidities or functional limitations, hindering personalized treatment decisions.
Purpose of the Study:
- To review existing obesity classification systems.
- To propose a novel, simple clinical and functional staging system for obesity.
Main Methods:
- Review of historical and current obesity classification systems.
- Development of a new clinical and functional staging framework.
Main Results:
- Existing anthropometric measures have limitations in clinical practice for individual obesity assessment.
- A new staging system is proposed to integrate morbidity and functional status.
Conclusions:
- The proposed clinical and functional staging system, alongside anthropometric measures, offers a practical framework for clinical decision-making in obesity.
- This system aims to improve the clinical management of individuals with obesity by considering health complications and functional impact.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...